Mr. Joe Atkins RN, MBA, CNN, CHT
Chief Executive Officer, Medical Concepts & Innovations
Member of the Healthcare Council
Council Member Biography
Joe Atkins, RN, MBA, CNN, CHT, is the Chief Executive Officer and Owner of Medical Concepts & Innovations. Mr. Atkins also works as a Dialysis Nurse. He serves as a Consultant for ESRD providers, manufacturers of dialysis supplies, and investment houses in New York and London. Mr. Atkins has set-up, owned, and operated his own facility and has assisted in the set-up of facilities for many clients, providing all required CMS paperwork for set-up and operations, and management. He is a Patented Inventor of dialysis related devices, most recently, a new permanent dialysis catheter system. Mr. Atkins is a published author with over 36 years of dialysis experience. His career in dialysis evolved, beginning as a Dialysis Technician, Nephrology Nurse and eventually moving into all phases of administration and operations. Mr. Atkins researches all major dialysis corporations, such as Amgen, Fresenius, DaVita, Baxter, Polypore-Membrana, Gambro, as well as the medium and small dialysis chains and all other dialysis related companies. (This is me - Update Profile)
Employment History
- 2005 - Unspecified
- Chief Executive Officer, Medical Concepts & Innovations
GLG NewsSM Analyses by Joe Atkins
GLG News is now G+ Insights
-
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
-
FDA Restrictions on ESA's Will Have Minimal Effect of EPO Usage.
August 4, 2008
Amgen Told to Reword Drug Label | www.nytimes.com
1) Concerns over the new FDA restrictions on ESA's is being overstated. 2) Amgen will continue to do well in the ESA market place, in spite of these changes. 3) J&J will receive the brunt of these changes, strictly because of their market concentration in the oncology market. 4) Amgen will continue on as the "King of US ESA's".
-
Veterans Admininstration Sets The Standard for Electronic Medical Records: Why Re-invent The Wheel?
August 4, 2008
Nationwide EHR Implementation Price Tag Estimated at $150 billion | www.govhealthit.com
The VA has already won many awards for an electronic medical records system, which tax payers have already paid for. Adopting the VA "CPRS" program would save the taxpayers and the private sector hundreds of billions of dollars.
-
FDA: Chinese Manufacturer of Tainted Heparin Involved in Fraud.
April 30, 2008
UPDATE: FDA Head Sees Economic Fraud Behind Tainted Heparin | www.reuters.com
First, and foremost, the only working link for this article can be found at: http://www.reuters.com/article/domesticNews/idUSWAT00934620080415?feedType=RSS&feedName=domesticNews Although there is no proof offered in the article to substantiate the suggestion of fraud, there is enough circumstantial evidence to suggest that it is so.
-
FDA Fees Must Be Increased to Fund Inspection of Chinese Products.
April 30, 2008
FDA fees eyed to boost food, drug safety | www.usatoday.com
One only has to read about the Heparin debacle, which has killed, at least, 81 Americans, to realize that there is a serious issue with the quality of medicines produced in China. Manufacturing of medical food and consumer goods in China is growing at such a rate, the Chinese government has neither the resources or the will to maintain adequate inspection of quality control. The only way it's going to be done is if our FDA becomes involved, hence the increase in FDA fees.
-
Who to Blame for Waste in the Medical Industry? Who's on First?
April 30, 2008
The Price of Excess: Identifying Waste in Healthcare Spending | blogs.wsj.com
It's easy to point fingers of blame and this article does that, very well. According to the "annalysis" everybody is to blame. And, they're right, everyone is to blame, but where the article fails is the authoris inability to point out a real solution to the problem of wasted dollars spent on the American healthcare system.
GLG Study Groups with Joe Atkins(?)
| Study Group Name | No. Members |
|---|---|
| Economic Experts on Managed Care | 804 |
| Managed Care Experts | 733 |
| Medicare Experts | 570 |
| Medical Device Experts | 513 |
| Medical Tourism Experts | 350 |
GLG Live Meetings with Joe Atkins(?)
Joe Atkins has not participated in any GLG Live Meetings.
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.